Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-641-8 | CAS number: 67-03-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Bächtold (1970): Under the conditions of this study the acute oral LD50 of the test material in mice was 13347 ± 1820 mg/kg bw.
Bächtold (1976): Under the conditions of this study the acute oral LD50 of the test material in rats was 12340 ± 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Mice of both sexes were once treated by oral gavage and then observed for 10 days for time of death. 10 different batches of the test material were tested and 3 different doses were used: 6000, 12000 and 24000 mg/kg bw. Each dose was tested in 10 animals.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- mouse
- Strain:
- not specified
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Doses:
- 6000, 12000 and 24000 mg/kg bw
- No. of animals per sex per dose:
- 10 animals per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 10 days
- Animals were observed for time of death - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 13 347 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 11 527 - <= 15 167
- Sex:
- male/female
- Dose descriptor:
- other: LD10
- Effect level:
- 9 136 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- other: LD90
- Effect level:
- 19 670 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All deaths occurred within 24 hours after dosing.
- Interpretation of results:
- other: Not classified in accordance with EU Criteria
- Conclusions:
- Under the conditions of this study the acute oral LD50 of the test material in mice was 13347 ± 1820 mg/kg bw.
- Executive summary:
The acute oral toxicity of the test material to mice was investigated.
Mice of both sexes were once treated by oral gavage and then observed for 10 days for time of death. 10 different batches of the test material were tested and 3 different doses were used: 6000, 12000 and 24000 mg/kg bw. Each dose was tested in 10 animals. No further information on study design was available.
All deaths occurred within 24 hours after dosing. LD50 was calculated to be >10000 mg/kg bw. This was true for each batch tested.
Under the conditions of this study the acute oral LD50 of the test material in mice was 13347 ± 1820 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 10 rats per dose were treated once by oral gavage and the animals were observed for 10 days for time of death.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- No. of animals per sex per dose:
- 10 animals per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 10 days
- Animals were observed for 10 days for time of death. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 12 340 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 10 340 - <= 14 340
- Sex:
- male/female
- Dose descriptor:
- other: LD10
- Effect level:
- 7 870 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- other: LD90
- Effect level:
- 19 400 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- other:
- Conclusions:
- Under the conditions of this study the acute oral LD50 of the test material in rats was12340 ± 2000mg/kg bw.
- Executive summary:
The acute oral toxicity of the test material to rats was investigated.
10 rats per dose were treated once by oral gavage and the animals were observed for 10 days for time of death. No further information available. The LD50 was calculated to be >10000 mg/kg bw.
Under the conditions of this study the acute oral LD50 of the test material in rats was12340 ± 2000mg/kg bw.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 12 340 mg/kg bw
- Quality of whole database:
- Only little information is given about study procedures, however the available data is sufficient to show that the test material is of low acute oral toxicity.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
ACUTE ORAL
Bächtold, mice (1970):
The acute oral toxicity of the test material to mice was investigated.
Mice of both sexes were once treated by oral gavage and then observed for 10 days for time of death. 10 different batches of the test material were tested and 3 different doses were used: 6000, 12000 and 24000 mg/kg bw. Each dose was tested in 10 animals. No further information on study design was available.
All deaths occurred within 24 hours after dosing. LD50 was calculated to be >10000 mg/kg bw. This was true for each batch tested.
Under the conditions of this study the acute oral LD50 of the test material in mice was 13347 ± 1820 mg/kg bw.
Bächtold, rats (1976):
The acute oral toxicity of the test material to rats was investigated.
10 rats per dose were treated once by oral gavage and the animals were observed for 10 days for time of death. No further information available. The LD50 was calculated to be > 10000 mg/kg bw.
Under the conditions of this study the acute oral LD50 of the test material in rats was 12340 ± 2000 mg/kg bw.
ACUTE INHALATION
In accordance with Column 2 of REACH, Annex VIII, information requirement 8.5.2 (acute toxicity by inhalation) testing is not appropriate as exposure of humans via inhalation is unlikely taking account of the operating conditions applied to substance manufacture and use and the risk manamegement measures that are applied. Furthermore, particle size distribution data indicates that the test material particles are too large to enter the airways (D10 = 23.64 µm; D50 = 50.11 µm, D90 = 90.01 µm) and are therefore not available to the airway to cause a toxic effect.
ACUTE DERMAL
In accordance with column 2 of REACH Annex VIII, information requirement 8.5.3 (acute toxicity by dermal route) testing is not considered to be appropriate because skin contact in production and/or use is unlikely. Furthermore, in vivo acute oral toxicity studies have revealed that the substance does not require classification for STOT-SE by the oral route, in vitro skin corrosion/irritation and skin sensitisation studies do not indicate effects following dermal exposure to the substance and no systemic toxicity is predicted.
Justification for classification or non-classification
Only little information is given about study procedures, however the available data is sufficient to show that the test material is of low acute oral toxicity. In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.